Pharmacotherapy for Schizophrenic Drug Users - 6

Phase 2

Completed

• Conditions: Substance-Related Disorders; Cocaine-Related Disorders; Shcizophrenia

• Registration Number: NCT00000281
• Lead Sponsor: Yale University

Brief Summary

The purpose of this study is to evaluate maintenance neuroleptics for Schizophrenic patients who are cocaine abusers.

Detailed Description

Not available

Study Timeline

• Study Start: 1994-09
• Primary Completion: 1999-08
• Study Completion: 1999-08
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Status Verified: 2016-12
• Last Update Submitted: 2016-12-13
• Last Update Posted: 2016-12-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Retention
Schizophrenic symptoms
Psychological symptoms
Drug use

Trial Locations

Locations (1)

VA Connecticut Healthcare System; 🇺🇸 New Haven, Connecticut, United States